{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:44:21Z","timestamp":1792147461589,"version":"4.4.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006706","name":"Tampereen Tuberkuloosis\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006706","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Tuberculosis (TB) treatment is increasingly challenged by both antimicrobial resistance (AMR) and phenotypic drug tolerance, the latter representing a reversible physiological state that contributes to persistence and prolonged therapy. While AMR is driven by heritable genetic mutations, drug tolerance arises from reversible physiological adaptations that enable bacterial survival during prolonged antibiotic exposure. Increasing evidence suggests that metabolic remodeling plays a central role in establishing these drug-tolerant states. Carbonic anhydrases (CAs) are zinc-containing metalloenzymes that catalyze the reversible interconversion of carbon dioxide and bicarbonate, thereby maintaining intracellular pH homeostasis and supporting bicarbonate-dependent metabolism. Beyond their established metabolic functions, indirect evidence suggests that CAs may contribute to physiological adaptations associated with bacterial persistence under host-imposed stresses, including hypoxia, nutrient limitation, and acidic environments. Although they are not classical AMR determinants, CAs may influence the metabolic landscape associated with phenotypic drug tolerance. In this review, we examine current evidence supporting the role of CAs in mycobacterial metabolism and propose a conceptual framework linking bicarbonate homeostasis, intracellular pH regulation, and metabolic adaptation to bacterial persistence and drug tolerance. We further discuss the potential of carbonic anhydrase inhibitors (CAIs) as adjunctive agents whose ability to enhance the activity of conventional antitubercular drugs requires experimental validation, together with the value of experimental models, including the\n                    <jats:italic>Mycobacterium marinum<\/jats:italic>\n                    \u2013zebrafish system, and computational approaches for validating CA-targeted therapeutic strategies. Overall, this review highlights CAs as candidate metabolic regulators that may influence the physiological state underlying phenotypic drug tolerance. Defining their mechanistic contribution to persistence could facilitate the development of metabolism-based therapeutic strategies that complement existing TB treatment.\n                  <\/jats:p>","DOI":"10.1007\/s00284-026-05196-3","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:47:19Z","timestamp":1792144039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Carbonic Anhydrases in Mycobacteria: Linking Metabolic Adaptation to Phenotypic Drug Tolerance"],"prefix":"10.1007","volume":"83","author":[{"given":"Maneesh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6938-7835","authenticated-orcid":false,"given":"Ashok","family":"Aspatwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"issue":"140","key":"5196_CR1","doi-asserted-by":"publisher","first-page":"140sr2","DOI":"10.1126\/scitranslmed.3003081","volume":"4","author":"C Nathan","year":"2012","unstructured":"Nathan C (2012) Fresh approaches to anti-infective therapies. Sci Transl Med 4(140):140sr2. https:\/\/doi.org\/10.1126\/scitranslmed.3003081","journal-title":"Sci Transl Med"},{"key":"5196_CR2","unstructured":"World Health Organization (2025) Global Tuberculosis Report. https:\/\/www.who.int\/publications\/i\/item\/9789240116924"},{"issue":"5","key":"5196_CR3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nrmicro.2016.34","volume":"14","author":"A Brauner","year":"2016","unstructured":"Brauner A, Fridman O, Gefen O et al (2016) Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat Rev Microbiol 14(5):320\u2013330. https:\/\/doi.org\/10.1038\/nrmicro.2016.34","journal-title":"Nat Rev Microbiol"},{"issue":"6327","key":"5196_CR4","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1126\/science.aaj2191","volume":"355","author":"I Levin-Reisman","year":"2017","unstructured":"Levin-Reisman I, Ronin I, Gefen O et al (2017) Antibiotic tolerance facilitates the evolution of resistance. Science 355(6327):826\u2013830. https:\/\/doi.org\/10.1126\/science.aaj2191","journal-title":"Science"},{"issue":"2","key":"5196_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/10409238.2013.869543","volume":"49","author":"JC Kester","year":"2014","unstructured":"Kester JC, Fortune SM (2014) Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria. Crit Rev Biochem Mol Biol 49(2):91\u2013101. https:\/\/doi.org\/10.3109\/10409238.2013.869543","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"1","key":"5196_CR6","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1080\/22221751.2020.1785334","volume":"9","author":"SS Swain","year":"2020","unstructured":"Swain SS, Sharma D, Hussain T et al (2020) Molecular mechanisms of underlying genetic factors and associated mutations for drug resistance in Mycobacterium tuberculosis. Emerg Microbes Infect 9(1):1651\u20131663. https:\/\/doi.org\/10.1080\/22221751.2020.1785334","journal-title":"Emerg Microbes Infect"},{"key":"5196_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fmicb.2013.00047","volume":"4","author":"S Sengupta","year":"2013","unstructured":"Sengupta S, Chattopadhyay MK, Grossart HP (2013) The multifaceted roles of antibiotics and antibiotic resistance in nature. Front Microbiol 4:47. https:\/\/doi.org\/10.3389\/fmicb.2013.00047","journal-title":"Front Microbiol"},{"key":"5196_CR8","doi-asserted-by":"publisher","first-page":"943545","DOI":"10.3389\/fcimb.2022.943545","volume":"12","author":"D Liebenberg","year":"2022","unstructured":"Liebenberg D, Gordhan BG, Kana BD (2022) Drug resistant tuberculosis: Implications for transmission, diagnosis, and disease management. Front Cell Infect Microbiol 12:943545. https:\/\/doi.org\/10.3389\/fcimb.2022.943545","journal-title":"Front Cell Infect Microbiol"},{"key":"5196_CR9","doi-asserted-by":"publisher","first-page":"612675","DOI":"10.3389\/fmicb.2021.612675","volume":"12","author":"A Allu\u00e9-Guardia","year":"2021","unstructured":"Allu\u00e9-Guardia A, Garc\u00eda JI, Torrelles JB (2021) Evolution of Drug-Resistant Mycobacterium tuberculosis Strains and Their Adaptation to the Human Lung Environment. Front Microbiol 12:612675. https:\/\/doi.org\/10.3389\/fmicb.2021.612675","journal-title":"Front Microbiol"},{"issue":"6","key":"5196_CR10","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1128\/jb.00926-09","volume":"192","author":"RL Leistikow","year":"2010","unstructured":"Leistikow RL, Morton RA, Bartek IL et al (2010) The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancy. J Bacteriol 192(6):1662\u20131670. https:\/\/doi.org\/10.1128\/jb.00926-09","journal-title":"J Bacteriol"},{"key":"5196_CR11","doi-asserted-by":"publisher","first-page":"958555","DOI":"10.3389\/fcimb.2022.958555","volume":"12","author":"AN Samuels","year":"2022","unstructured":"Samuels AN, Wang ER, Harrison GA et al (2022) Understanding the contribution of metabolism to Mycobacterium tuberculosis drug tolerance. Front Cell Infect Microbiol 12:958555. https:\/\/doi.org\/10.3389\/fcimb.2022.958555","journal-title":"Front Cell Infect Microbiol"},{"key":"5196_CR12","doi-asserted-by":"publisher","first-page":"1437901","DOI":"10.3389\/fimmu.2024.1437901","volume":"15","author":"F Rahman","year":"2024","unstructured":"Rahman F (2024) Characterizing the immune response to Mycobacterium tuberculosis: a comprehensive narrative review and implications in disease relapse. Front Immunol 15:1437901. https:\/\/doi.org\/10.3389\/fimmu.2024.1437901","journal-title":"Front Immunol"},{"issue":"5","key":"5196_CR13","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1165\/rcmb.2016-0239OC","volume":"56","author":"TA Hudock","year":"2017","unstructured":"Hudock TA, Foreman TW, Bandyopadhyay N et al (2017) Hypoxia Sensing and Persistence Genes Are Expressed during the Intragranulomatous Survival of Mycobacterium tuberculosis. Am J Respir Cell Mol Biol 56(5):637\u2013647. https:\/\/doi.org\/10.1165\/rcmb.2016-0239OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"5196_CR14","doi-asserted-by":"publisher","unstructured":"Huang L, Nazarova EV, Russell DG (2019) Mycobacterium tuberculosis: Bacterial fitness within the host macrophage. Microbiol Spectr 7(2). https:\/\/doi.org\/10.1128\/microbiolspec.BAI-0001-2019","DOI":"10.1128\/microbiolspec.BAI-0001-2019"},{"issue":"3","key":"5196_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.micinf.2016.10.001","volume":"19","author":"G Prosser","year":"2017","unstructured":"Prosser G, Brandenburg J, Reiling N et al (2017) The bacillary and macrophage response to hypoxia in tuberculosis and the consequences for T cell antigen recognition. Microbes Infect 19(3):177\u2013192. https:\/\/doi.org\/10.1016\/j.micinf.2016.10.001","journal-title":"Microbes Infect"},{"key":"5196_CR16","doi-asserted-by":"publisher","first-page":"956607","DOI":"10.3389\/fcimb.2022.956607","volume":"12","author":"T Parbhoo","year":"2022","unstructured":"Parbhoo T, Mouton JM, Sampson SL (2022) Phenotypic adaptation of Mycobacterium tuberculosis to host-associated stressors that induce persister formation. Front Cell Infect Microbiol 12:956607. https:\/\/doi.org\/10.3389\/fcimb.2022.956607","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"5196_CR17","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3390\/ijms26041621","volume":"26","author":"MJ Nasiri","year":"2025","unstructured":"Nasiri MJ, Venketaraman V (2025) Advances in Host-Pathogen Interactions in Tuberculosis: Emerging Strategies for Therapeutic Intervention. Int J Mol Sci 26(4):1621. https:\/\/doi.org\/10.3390\/ijms26041621","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5196_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/metabo7040056","volume":"7","author":"CT Supuran","year":"2017","unstructured":"Supuran CT, Capasso C (2017) An overview of the bacterial carbonic anhydrases. Metabolites 7(4):56. https:\/\/doi.org\/10.3390\/metabo7040056","journal-title":"Metabolites"},{"issue":"3","key":"5196_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/17460441.2026.2636772","volume":"21","author":"R Bhowmik","year":"2026","unstructured":"Bhowmik R, D\u2019Agostino I, Angeli A et al (2026) Integrated in silico and in vitro screening approaches for the discovery of small-molecule inhibitors of \u03b2-carbonic anhydrases. Expert Opin Drug Discov 21(3):319\u2013337. https:\/\/doi.org\/10.1080\/17460441.2026.2636772","journal-title":"Expert Opin Drug Discov"},{"key":"5196_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/bs.enz.2024.05.012","volume":"55","author":"J Parkkinen","year":"2024","unstructured":"Parkkinen J, Bhowmik R, Tolvanen M et al (2024) Mycobacterial \u03b2-carbonic anhydrases: Molecular biology, role in the pathogenesis of tuberculosis and inhibition studies. Enzymes 55:343\u2013381. https:\/\/doi.org\/10.1016\/bs.enz.2024.05.012","journal-title":"Enzymes"},{"key":"5196_CR21","doi-asserted-by":"publisher","first-page":"1457012","DOI":"10.3389\/fphar.2024.1457012","volume":"15","author":"A Manaithiya","year":"2024","unstructured":"Manaithiya A, Bhowmik R, Bhattacharya K et al (2024) A cheminformatics and network pharmacology approach to elucidate the mechanism of action of Mycobacterium tuberculosis \u03b3-carbonic anhydrase inhibitors. Front Pharmacol 15:1457012. https:\/\/doi.org\/10.3389\/fphar.2024.1457012","journal-title":"Front Pharmacol"},{"issue":"1","key":"5196_CR22","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1080\/14756366.2017.1332056","volume":"32","author":"A Aspatwar","year":"2017","unstructured":"Aspatwar A, Hammar\u00e9n M, Koskinen S et al (2017) \u03b2-CA-specific inhibitor dithiocarbamate Fc14-584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis. J Enzyme Inhib Med Chem 32(1):832\u2013840. https:\/\/doi.org\/10.1080\/14756366.2017.1332056","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"20","key":"5196_CR23","doi-asserted-by":"publisher","first-page":"5153","DOI":"10.3390\/ijms20205153","volume":"20","author":"A Aspatwar","year":"2019","unstructured":"Aspatwar A, Kairys V, Rala S et al (2019) Mycobacterium tuberculosis beta-Carbonic Anhydrases: Novel Targets for Developing Antituberculosis Drugs. Int J Mol Sci 20(20):5153. https:\/\/doi.org\/10.3390\/ijms20205153","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5196_CR24","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.bmcl.2012.11.085","volume":"23","author":"MV Buchieri","year":"2013","unstructured":"Buchieri MV, Riafrecha LE, Rodr\u00edguez OM et al (2013) Inhibition of the \u03b2-carbonic anhydrases from Mycobacterium tuberculosis with C-cinnamoyl glycosides: identification of the first inhibitor with anti-mycobacterial activity. Bioorg Med Chem Lett 23(3):740\u2013743. https:\/\/doi.org\/10.1016\/j.bmcl.2012.11.085","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"5196_CR25","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1152\/physrev.00018.2021","volume":"102","author":"A Aspatwar","year":"2022","unstructured":"Aspatwar A, Tolvanen ME, Barker H et al (2022) Carbonic anhydrases in metazoan model organisms: molecules, mechanisms, and physiology. Physiol Rev 102(3):1327\u20131383. https:\/\/doi.org\/10.1152\/physrev.00018.2021","journal-title":"Physiol Rev"},{"issue":"1","key":"5196_CR26","doi-asserted-by":"publisher","first-page":"2474865","DOI":"10.1080\/21505594.2025.2474865","volume":"16","author":"A Aspatwar","year":"2025","unstructured":"Aspatwar A, Parkkinen J, Parkkila S (2025) Physiological role of bicarbonate in microbes: A double-edged. sword? Virulence 16(1):2474865. https:\/\/doi.org\/10.1080\/21505594.2025.2474865","journal-title":"sword? Virulence"},{"key":"5196_CR27","doi-asserted-by":"publisher","first-page":"6926082","DOI":"10.1155\/2021\/6926082","volume":"2021","author":"A Amedei","year":"2021","unstructured":"Amedei A, Capasso C, Nannini G et al (2021) Microbiota, Bacterial Carbonic Anhydrases, and Modulators of Their Activity: Links to Human Diseases? Mediators Inflamm 2021:6926082. https:\/\/doi.org\/10.1155\/2021\/6926082","journal-title":"Mediators Inflamm"},{"issue":"1","key":"5196_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/antibiotics12010142","volume":"12","author":"A Nocentini","year":"2023","unstructured":"Nocentini A, Capasso C, Supuran CT (2023) Carbonic Anhydrase Inhibitors as Novel Antibacterials in the Era of Antibiotic Resistance: Where Are We Now? Antibiot (Basel) 12(1):142. https:\/\/doi.org\/10.3390\/antibiotics12010142","journal-title":"Antibiot (Basel)"},{"issue":"6","key":"5196_CR29","doi-asserted-by":"publisher","first-page":"e01597","DOI":"10.1128\/mbio.01597-16","volume":"7","author":"SJ Rose","year":"2016","unstructured":"Rose SJ, Bermudez LE (2016) Identification of Bicarbonate as a Trigger and Genes Involved with Extracellular DNA Export in Mycobacterial Biofilms. mBio 7(6):e01597\u2013e01516. https:\/\/doi.org\/10.1128\/mbio.01597-16","journal-title":"mBio"},{"issue":"8","key":"5196_CR30","doi-asserted-by":"publisher","first-page":"4436","DOI":"10.1128\/aac.00719-15","volume":"59","author":"BK Johnson","year":"2015","unstructured":"Johnson BK, Colvin CJ, Needle DB et al (2015) The carbonic anhydrase inhibitor ethoxzolamide inhibits the Mycobacterium tuberculosis PhoPR regulon and Esx-1 secretion and attenuates virulence. Antimicrob Agents Chemother 59(8):4436\u20134445. https:\/\/doi.org\/10.1128\/aac.00719-15","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"5196_CR31","doi-asserted-by":"publisher","first-page":"e00568","DOI":"10.1128\/iai.00568-24","volume":"93","author":"SJ Dechow","year":"2025","unstructured":"Dechow SJ, Goyal R, Johnson BK et al (2025) Carbon dioxide regulates Mycobacterium tuberculosis PhoPR signaling and virulence. Infect Immun 93(3):e00568\u2013e00524. https:\/\/doi.org\/10.1128\/iai.00568-24","journal-title":"Infect Immun"},{"issue":"5","key":"5196_CR32","doi-asserted-by":"publisher","first-page":"001458","DOI":"10.1099\/mic.0.001458","volume":"170","author":"SJ Dechow","year":"2024","unstructured":"Dechow SJ, Abramovitch RB (2024) Targeting Mycobacterium tuberculosis pH-driven adaptation. Microbiology 170(5):001458. https:\/\/doi.org\/10.1099\/mic.0.001458","journal-title":"Microbiology"},{"issue":"2","key":"5196_CR33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1113\/JP283579","volume":"601","author":"A Aspatwar","year":"2023","unstructured":"Aspatwar A, Supuran CT, Waheed A et al (2023) Mitochondrial carbonic anhydrase VA and VB: properties and roles in health and disease. J Physiol 601(2):257\u2013274. https:\/\/doi.org\/10.1113\/JP283579","journal-title":"J Physiol"},{"issue":"15","key":"5196_CR34","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.3390\/ijms20153841","volume":"20","author":"R Occhipinti","year":"2019","unstructured":"Occhipinti R, Boron WF (2019) Role of Carbonic Anhydrases and Inhibitors in Acid-Base Physiology: Insights from Mathematical Modeling. Int J Mol Sci 20(15):3841. https:\/\/doi.org\/10.3390\/ijms20153841","journal-title":"Int J Mol Sci"},{"key":"5196_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mib.2017.11.020","volume":"41","author":"G Gago","year":"2018","unstructured":"Gago G, Diacovich L, Gramajo H (2018) Lipid metabolism and its implication in mycobacteria-host interaction. Curr Opin Microbiol 41:36\u201342. https:\/\/doi.org\/10.1016\/j.mib.2017.11.020","journal-title":"Curr Opin Microbiol"},{"issue":"2","key":"5196_CR36","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/metabo11020088","volume":"11","author":"DPS Chang","year":"2021","unstructured":"Chang DPS, Guan XL (2021) Metabolic Versatility of Mycobacterium tuberculosis during Infection and Dormancy. Metabolites 11(2):88. https:\/\/doi.org\/10.3390\/metabo11020088","journal-title":"Metabolites"},{"issue":"1","key":"5196_CR37","doi-asserted-by":"publisher","first-page":"ftac032","DOI":"10.1093\/femspd\/ftac032","volume":"80","author":"R Rai","year":"2022","unstructured":"Rai R, Singh V, Mathew BJ et al (2022) Mycobacterial response to an acidic environment: protective mechanisms. Pathog Dis 80(1):ftac032. https:\/\/doi.org\/10.1093\/femspd\/ftac032","journal-title":"Pathog Dis"},{"issue":"8","key":"5196_CR38","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/j.1462-5822.2009.01335.x","volume":"11","author":"S Ehrt","year":"2009","unstructured":"Ehrt S, Schnappinger D (2009) Mycobacterial survival strategies in the phagosome: defence against host stresses. Cell Microbiol 11(8):1170\u20131178. https:\/\/doi.org\/10.1111\/j.1462-5822.2009.01335.x","journal-title":"Cell Microbiol"},{"key":"5196_CR39","doi-asserted-by":"publisher","unstructured":"Banerjee A, Sengupta S, Nandanwar N et al (2023) Mycobacterium tuberculosis adaptation to host environment. In: Kumar A, Tenguria S (eds) Bacterial Survival in the Hostile Environment. Academic Press, pp 1\u201314. https:\/\/doi.org\/10.1016\/B978-0-323-91806-0.00005-9","DOI":"10.1016\/B978-0-323-91806-0.00005-9"},{"issue":"13","key":"5196_CR40","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1128\/jb.184.13.3485-3491","volume":"184","author":"I Rosenkrands","year":"2002","unstructured":"Rosenkrands I, Slayden RA, Crawford J et al (2002) Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteome analysis of cellular and extracellular proteins. J Bacteriol 184(13):3485\u20133491. https:\/\/doi.org\/10.1128\/jb.184.13.3485-3491","journal-title":"J Bacteriol"},{"issue":"7","key":"5196_CR41","doi-asserted-by":"publisher","first-page":"e00705","DOI":"10.1128\/jb.00705-19","volume":"202","author":"PR Singh","year":"2020","unstructured":"Singh PR, Vijjamarri AK, Sarkar D (2020) Metabolic Switching of Mycobacterium tuberculosis during Hypoxia Is Controlled by the Virulence Regulator PhoP. J Bacteriol 202(7):e00705\u2013e00719. https:\/\/doi.org\/10.1128\/jb.00705-19","journal-title":"J Bacteriol"},{"key":"5196_CR42","doi-asserted-by":"publisher","unstructured":"Mashabela GT, de Wet TJ, Warner DF (2019) Mycobacterium tuberculosis metabolism. Microbiol Spectr 7(4). https:\/\/doi.org\/10.1128\/microbiolspec.GPP3-0067-2019","DOI":"10.1128\/microbiolspec.GPP3-0067-2019"},{"issue":"9","key":"5196_CR43","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3390\/microorganisms8091380","volume":"8","author":"AC Pereira","year":"2020","unstructured":"Pereira AC, Ramos B, Reis AC et al (2020) Non-Tuberculous Mycobacteria: Molecular and Physiological Bases of Virulence and Adaptation to Ecological Niches. Microorganisms 8(9):1380. https:\/\/doi.org\/10.3390\/microorganisms8091380","journal-title":"Microorganisms"},{"issue":"10","key":"5196_CR44","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1109\/TBME.2016.2605701","volume":"63","author":"EE May","year":"2016","unstructured":"May EE, Sershen CL (2016) Oxygen Availability and Metabolic Dynamics During Mycobacterium tuberculosis Latency. IEEE Trans Biomed Eng 63(10):2036\u20132046. https:\/\/doi.org\/10.1109\/TBME.2016.2605701","journal-title":"IEEE Trans Biomed Eng"},{"key":"5196_CR45","doi-asserted-by":"publisher","first-page":"1062963","DOI":"10.3389\/fcimb.2023.1062963","volume":"13","author":"H Bo","year":"2023","unstructured":"Bo H, Moure UA, Yang Y et al (2023) Mycobacterium tuberculosis-macrophage interaction: Molecular updates. Front Cell Infect Microbiol 13:1062963. https:\/\/doi.org\/10.3389\/fcimb.2023.1062963","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"5196_CR46","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1111\/febs.14046","volume":"284","author":"B Bazet Lyonnet","year":"2017","unstructured":"Bazet Lyonnet B, Diacovich L, Gago G et al (2017) Functional reconstitution of the Mycobacterium tuberculosis long-chain acyl-CoA carboxylase from multiple acyl-CoA subunits. FEBS J 284(7):1110\u20131125. https:\/\/doi.org\/10.1111\/febs.14046","journal-title":"FEBS J"},{"issue":"5","key":"5196_CR47","doi-asserted-by":"publisher","first-page":"e1001065","DOI":"10.1371\/journal.pbio.1001065","volume":"9","author":"SH Baek","year":"2011","unstructured":"Baek SH, Li AH, Sassetti CM (2011) Metabolic regulation of mycobacterial growth and antibiotic sensitivity. PLoS Biol 9(5):e1001065. https:\/\/doi.org\/10.1371\/journal.pbio.1001065","journal-title":"PLoS Biol"},{"issue":"7","key":"5196_CR48","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s00204-016-1727-6","volume":"90","author":"L Nguyen","year":"2016","unstructured":"Nguyen L (2016) Antibiotic resistance mechanisms in M. tuberculosis: an update. Arch Toxicol 90(7):1585\u20131604. https:\/\/doi.org\/10.1007\/s00204-016-1727-6","journal-title":"Arch Toxicol"},{"issue":"27","key":"5196_CR49","doi-asserted-by":"publisher","first-page":"8173","DOI":"10.1073\/pnas.1509743112","volume":"112","author":"MA Lobritz","year":"2015","unstructured":"Lobritz MA, Belenky P, Porter CB et al (2015) Antibiotic efficacy is linked to bacterial cellular respiration. Proc Natl Acad Sci U S A 112(27):8173\u20138180. https:\/\/doi.org\/10.1073\/pnas.1509743112","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5196_CR50","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1038\/s41467-023-38859-x","volume":"14","author":"S Chowdhury","year":"2023","unstructured":"Chowdhury S, Zielinski DC, Dalldorf C et al (2023) Empowering drug off-target discovery with metabolic and structural analysis. Nat Commun 14(1):3390. https:\/\/doi.org\/10.1038\/s41467-023-38859-x","journal-title":"Nat Commun"},{"issue":"5","key":"5196_CR51","doi-asserted-by":"publisher","first-page":"001333","DOI":"10.1099\/mic.0.001333","volume":"169","author":"A Gaurav","year":"2023","unstructured":"Gaurav A, Bakht P, Saini M et al (2023) Role of bacterial efflux pumps in antibiotic resistance, virulence, and strategies to discover novel efflux pump inhibitors. Microbiol (Reading) 169(5):001333. https:\/\/doi.org\/10.1099\/mic.0.001333","journal-title":"Microbiol (Reading)"},{"issue":"2","key":"5196_CR52","doi-asserted-by":"publisher","first-page":"BSR20211215","DOI":"10.1042\/BSR20211215","volume":"42","author":"Y Xu","year":"2022","unstructured":"Xu Y, Pooja, Borah K (2022) Mycobacterium tuberculosis carbon and nitrogen metabolic fluxes. Biosci Rep 42(2):BSR20211215. https:\/\/doi.org\/10.1042\/BSR20211215","journal-title":"Biosci Rep"},{"issue":"11","key":"5196_CR53","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.3390\/molecules23112911","volume":"23","author":"A Aspatwar","year":"2018","unstructured":"Aspatwar A, Winum JY, Carta F et al (2018) Carbonic Anhydrase Inhibitors as Novel Drugs against Mycobacterial beta-Carbonic Anhydrases: An Update on In Vitro and. Vivo Stud Molecules 23(11):2911. https:\/\/doi.org\/10.3390\/molecules23112911","journal-title":"Vivo Stud Molecules"},{"key":"5196_CR54","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/bs.enz.2024.05.006","volume":"55","author":"CT Supuran","year":"2024","unstructured":"Supuran CT (2024) Challenges for developing bacterial CA inhibitors as novel antibiotics. Enzymes 55:383\u2013411. https:\/\/doi.org\/10.1016\/bs.enz.2024.05.006","journal-title":"Enzymes"},{"issue":"1","key":"5196_CR55","doi-asserted-by":"publisher","first-page":"e00141","DOI":"10.1128\/cmr.00141-20","volume":"34","author":"SN Goossens","year":"2020","unstructured":"Goossens SN, Sampson SL, Van Rie A (2020) Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis. Clin Microbiol Rev 34(1):e00141\u2013e00120. https:\/\/doi.org\/10.1128\/cmr.00141-20","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"5196_CR56","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41579-022-00731-y","volume":"20","author":"VA Dartois","year":"2022","unstructured":"Dartois VA, Rubin EJ (2022) Anti-tuberculosis treatment strategies and drug development: challenges and priorities. Nat Rev Microbiol 20(11):685\u2013701. https:\/\/doi.org\/10.1038\/s41579-022-00731-y","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"5196_CR57","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s43556-024-00243-6","volume":"6","author":"Y An","year":"2025","unstructured":"An Y, Ni R, Zhuang L et al (2025) Tuberculosis vaccines and therapeutic drug: challenges and future directions. Mol Biomed 6(1):4. https:\/\/doi.org\/10.1186\/s43556-024-00243-6","journal-title":"Mol Biomed"},{"issue":"6","key":"5196_CR58","doi-asserted-by":"publisher","first-page":"e0145623","DOI":"10.1128\/aac.01456-23","volume":"68","author":"C Bernard","year":"2024","unstructured":"Bernard C, Liu Y, Larrouy-Maumus G et al (2024) Altered serine metabolism promotes drug tolerance in Mycobacterium abscessus via a WhiB7-mediated adaptive stress response. Antimicrob Agents Chemother 68(6):e0145623. https:\/\/doi.org\/10.1128\/aac.01456-23","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"5196_CR59","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mib.2006.12.007","volume":"10","author":"N Dhar","year":"2007","unstructured":"Dhar N, McKinney JD (2007) Microbial phenotypic heterogeneity and antibiotic tolerance. Curr Opin Microbiol 10(1):30\u201338. https:\/\/doi.org\/10.1016\/j.mib.2006.12.007","journal-title":"Curr Opin Microbiol"},{"issue":"2","key":"5196_CR60","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/metabo8020025","volume":"8","author":"CT Supuran","year":"2018","unstructured":"Supuran CT (2018) Carbonic Anhydrases and Metabolism. Metabolites 8(2):25. https:\/\/doi.org\/10.3390\/metabo8020025","journal-title":"Metabolites"},{"issue":"7","key":"5196_CR61","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41579-025-01155-0","volume":"23","author":"M Ahmad","year":"2025","unstructured":"Ahmad M, Aduru SV, Smith RP et al (2025) The role of bacterial metabolism in antimicrobial resistance. Nat Rev Microbiol 23(7):439\u2013454. https:\/\/doi.org\/10.1038\/s41579-025-01155-0","journal-title":"Nat Rev Microbiol"},{"issue":"28","key":"5196_CR62","doi-asserted-by":"publisher","first-page":"25209","DOI":"10.1021\/acsomega.3c02311","volume":"8","author":"G Degiacomi","year":"2023","unstructured":"Degiacomi G, Gianibbi B, Recchia D et al (2023) CanB, a Druggable Cellular Target in Mycobacterium tuberculosis. ACS Omega 8(28):25209\u201325220. https:\/\/doi.org\/10.1021\/acsomega.3c02311","journal-title":"ACS Omega"},{"issue":"1","key":"5196_CR63","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/14756366.2019.1683007","volume":"35","author":"A Aspatwar","year":"2020","unstructured":"Aspatwar A, Hammar\u00e9n M, Parikka M et al (2020) In vitro inhibition of Mycobacterium tuberculosis beta-carbonic anhydrase 3 with Mono- and dithiocarbamates and evaluation of their toxicity using zebrafish developing embryos. J Enzyme Inhib Med Chem 35(1):65\u201371. https:\/\/doi.org\/10.1080\/14756366.2019.1683007","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"12","key":"5196_CR64","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1517\/14728222.2015.1067685","volume":"19","author":"C Capasso","year":"2015","unstructured":"Capasso C, Supuran CT (2015) Bacterial, fungal and protozoan carbonic anhydrases as drug targets. Expert Opin Ther Targets 19(12):1689\u20131704. https:\/\/doi.org\/10.1517\/14728222.2015.1067685","journal-title":"Expert Opin Ther Targets"},{"issue":"13","key":"5196_CR65","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.1073\/pnas.1400390111","volume":"111","author":"H Eoh","year":"2014","unstructured":"Eoh H, Rhee KY (2014) Methylcitrate cycle defines the bactericidal essentiality of isocitrate lyase for survival of Mycobacterium tuberculosis on fatty acids. Proc Natl Acad Sci U S A 111(13):4976\u20134981. https:\/\/doi.org\/10.1073\/pnas.1400390111","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"5196_CR66","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1042\/BCJ20160115","volume":"473","author":"CT Supuran","year":"2016","unstructured":"Supuran CT (2016) Structure and function of carbonic anhydrases. Biochem J 473(14):2023\u20132032. https:\/\/doi.org\/10.1042\/BCJ20160115","journal-title":"Biochem J"},{"issue":"6","key":"5196_CR67","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/13543776.2024.2332663","volume":"34","author":"C Capasso","year":"2024","unstructured":"Capasso C, Supuran CT (2024) Carbonic anhydrase and bacterial metabolism: a chance for antibacterial drug discovery. Expert Opin Ther Pat 34(6):465\u2013474. https:\/\/doi.org\/10.1080\/13543776.2024.2332663","journal-title":"Expert Opin Ther Pat"},{"key":"5196_CR68","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/bs.enz.2024.06.006","volume":"55","author":"A Nocentini","year":"2024","unstructured":"Nocentini A (2024) Sulfonamide inhibitors of bacterial carbonic anhydrases. Enzymes 55:143\u2013191. https:\/\/doi.org\/10.1016\/bs.enz.2024.06.006","journal-title":"Enzymes"},{"issue":"1","key":"5196_CR69","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1186\/s12866-025-04361-1","volume":"25","author":"MM Shalaby","year":"2025","unstructured":"Shalaby MM, Samir R, Ibrahim KA et al (2025) Computational guided identification of novel anti-mycobacterial agent proved by in-vitro and in-vivo validation. BMC Microbiol 25(1):576. https:\/\/doi.org\/10.1186\/s12866-025-04361-1","journal-title":"BMC Microbiol"},{"key":"5196_CR70","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3389\/fimmu.2017.01703","volume":"8","author":"N Yoshida","year":"2017","unstructured":"Yoshida N, Frickel EM, Mostowy S (2017) Macrophage-microbe interactions: lessons from the zebrafish model. Front Immunol 8:1703. https:\/\/doi.org\/10.3389\/fimmu.2017.01703","journal-title":"Front Immunol"},{"key":"5196_CR71","doi-asserted-by":"publisher","first-page":"1265573","DOI":"10.3389\/fphar.2023.1265573","volume":"14","author":"R Bhowmik","year":"2023","unstructured":"Bhowmik R, Kant R, Manaithiya A et al (2023) Navigating bioactivity space in anti-tubercular drug discovery through the deployment of advanced machine learning models and cheminformatics tools: a molecular modeling based retrospective study. Front Pharmacol 14:1265573. https:\/\/doi.org\/10.3389\/fphar.2023.1265573","journal-title":"Front Pharmacol"},{"issue":"2","key":"5196_CR72","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/jac\/dkw421","volume":"72","author":"JP Dalton","year":"2017","unstructured":"Dalton JP, Uy B, Okuda KS et al (2017) Screening of anti-mycobacterial compounds in a naturally infected zebrafish larvae model. J Antimicrob Chemother 72(2):421\u2013427. https:\/\/doi.org\/10.1093\/jac\/dkw421","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"5196_CR73","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3390\/pathogens14090908","volume":"14","author":"P Kumar","year":"2025","unstructured":"Kumar P, Cameron J, Saviola B et al (2025) Mycobacterium marinum Immune Evasion in Zebrafish. Pathogens 14(9):908. https:\/\/doi.org\/10.3390\/pathogens14090908","journal-title":"Pathogens"},{"key":"5196_CR74","doi-asserted-by":"publisher","first-page":"108749","DOI":"10.1016\/j.micpath.2026.108749","volume":"219","author":"A Aspatwar","year":"2026","unstructured":"Aspatwar A (2026) Mycobacterium marinum as a surrogate model for tuberculosis pathogenesis and drug discovery. Microb Pathog 219:108749. https:\/\/doi.org\/10.1016\/j.micpath.2026.108749","journal-title":"Microb Pathog"},{"issue":"5","key":"5196_CR75","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/j.1462-5822.2008.01133.x","volume":"10","author":"DM Tobin","year":"2008","unstructured":"Tobin DM, Ramakrishnan L (2008) Comparative pathogenesis of Mycobacterium marinum and Mycobacterium tuberculosis. Cell Microbiol 10(5):1027\u20131039. https:\/\/doi.org\/10.1111\/j.1462-5822.2008.01133.x","journal-title":"Cell Microbiol"},{"key":"5196_CR76","doi-asserted-by":"publisher","first-page":"1735950","DOI":"10.3389\/ftubr.2025.1735950","volume":"3","author":"M Cortacans","year":"2025","unstructured":"Cortacans M, Cardona PJ (2025) Mycobacteria as evolutionary drivers of host innate immunity: insights from comparing experimental host models. Front Tuberc 3:1735950. https:\/\/doi.org\/10.3389\/ftubr.2025.1735950","journal-title":"Front Tuberc"},{"issue":"11","key":"5196_CR77","doi-asserted-by":"publisher","first-page":"6108","DOI":"10.1128\/iai.00887-06","volume":"74","author":"LE Swaim","year":"2006","unstructured":"Swaim LE, Connolly LE, Volkman HE et al (2006) Mycobacterium marinum infection of adult zebrafish causes caseating granulomatous tuberculosis and is moderated by adaptive immunity. Infect Immun 74(11):6108\u20136117. https:\/\/doi.org\/10.1128\/iai.00887-06","journal-title":"Infect Immun"},{"issue":"8","key":"5196_CR78","doi-asserted-by":"publisher","first-page":"4342","DOI":"10.3390\/ijms23084342","volume":"23","author":"A Aspatwar","year":"2022","unstructured":"Aspatwar A, Syrj\u00e4nen L, Parkkila S (2022) Roles of Carbonic Anhydrases and Carbonic Anhydrase Related Proteins in Zebrafish. Int J Mol Sci 23(8):4342. https:\/\/doi.org\/10.3390\/ijms23084342","journal-title":"Int J Mol Sci"},{"key":"5196_CR79","doi-asserted-by":"publisher","first-page":"1427559","DOI":"10.3389\/fimmu.2024.1427559","volume":"15","author":"J Lyu","year":"2024","unstructured":"Lyu J, Narum DE, Baldwin SL et al (2024) Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals. Front Immunol 15:1427559. https:\/\/doi.org\/10.3389\/fimmu.2024.1427559","journal-title":"Front Immunol"},{"key":"5196_CR80","doi-asserted-by":"publisher","first-page":"117793222614271","DOI":"10.1177\/11779322261427120","volume":"20","author":"N Morshed","year":"2026","unstructured":"Morshed N, Reza MS, Bhowmik R et al (2026) Computational and Experimental Characterization of Mycobacterium marinum \u03b2-Carbonic Anhydrase Inhibitors. Bioinform Biol Insights 20:11779322261427120. https:\/\/doi.org\/10.1177\/11779322261427120","journal-title":"Bioinform Biol Insights"},{"issue":"4","key":"5196_CR81","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ijmyco.2014.10.001","volume":"3","author":"JP Sridevi","year":"2014","unstructured":"Sridevi JP, Anantaraju HS, Kulkarni P et al (2014) Optimization and validation of Mycobacterium marinum-induced adult zebrafish model for evaluation of oral anti-tuberculosis drugs. Int J Mycobacteriol 3(4):259\u2013267. https:\/\/doi.org\/10.1016\/j.ijmyco.2014.10.001","journal-title":"Int J Mycobacteriol"},{"issue":"1","key":"5196_CR82","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/14756366.2019.1685510","volume":"35","author":"A Aspatwar","year":"2020","unstructured":"Aspatwar A, Parvathaneni NK, Barker H et al (2020) Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series. J Enzyme Inhib Med Chem 35(1):109\u2013117. https:\/\/doi.org\/10.1080\/14756366.2019.1685510","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"3","key":"5196_CR83","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/01480545.2016.1223095","volume":"40","author":"J Kazokait\u0117","year":"2017","unstructured":"Kazokait\u0117 J, Aspatwar A, Kairys V et al (2017) Fluorinated benzenesulfonamide anticancer inhibitors of carbonic anhydrase IX exhibit lower toxic effects on zebrafish embryonic development than ethoxzolamide. Drug Chem Toxicol 40(3):309\u2013319. https:\/\/doi.org\/10.1080\/01480545.2016.1223095","journal-title":"Drug Chem Toxicol"},{"key":"5196_CR84","doi-asserted-by":"publisher","first-page":"e59315","DOI":"10.3791\/59315","volume":"150","author":"A Aspatwar","year":"2019","unstructured":"Aspatwar A, Hammar\u00e9n MM, Parikka M et al (2019) Rapid Evaluation of Toxicity of Chemical Compounds Using Zebrafish Embryos. J Vis Exp 150:e59315. https:\/\/doi.org\/10.3791\/59315","journal-title":"J Vis Exp"},{"issue":"10","key":"5196_CR85","doi-asserted-by":"publisher","first-page":"e00801","DOI":"10.1128\/AAC.00801-20","volume":"64","author":"S Commandeur","year":"2020","unstructured":"Commandeur S, Iakobachvili N, Sparrius M et al (2020) Zebrafish Embryo Model for Assessment of Drug Efficacy on Mycobacterial Persisters. Antimicrob Agents Chemother 64(10):e00801\u2013e00820. https:\/\/doi.org\/10.1128\/AAC.00801-20","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"5196_CR86","doi-asserted-by":"publisher","first-page":"e00057","DOI":"10.1128\/mSystems.00057-17","volume":"2","author":"M Zimmermann","year":"2017","unstructured":"86, Zimmermann M, Kogadeeva M, Gengenbacher M et al (2017) Integration of Metabolomics and Transcriptomics Reveals a Complex Diet of Mycobacterium tuberculosis during Early Macrophage Infection. mSystems 2(4):e00057\u2013e00017. https:\/\/doi.org\/10.1128\/mSystems.00057-17","journal-title":"mSystems"},{"issue":"12","key":"5196_CR87","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.3390\/ijms26125574","volume":"26","author":"C Acierno","year":"2025","unstructured":"Acierno C, Barletta F, Nevola R et al (2025) Metabolic Rewiring of Bacterial Pathogens in Response to Antibiotic Pressure-A Molecular Perspective. Int J Mol Sci 26(12):5574. https:\/\/doi.org\/10.3390\/ijms26125574","journal-title":"Int J Mol Sci"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-05196-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-026-05196-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-05196-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:47:21Z","timestamp":1792144041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-026-05196-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":87,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["5196"],"URL":"https:\/\/doi.org\/10.1007\/s00284-026-05196-3","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"27 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"594"}}